Latest / Stock Movers / Blue Owl Lower, Globalstar Rises, Tesla Slides
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: I'm Jim Stenoveek with Carol Masser. We are joined by
- 0:20Speaker 3: Bloomberg Television Markets correspondent Nora Melnda for some stocks on
- 0:24Speaker 3: the move.
- 0:26Speaker 1: What do you got, Nora, So we.
- 0:28Speaker 4: Can't stop talking about Nike. That's what I've got in
- 0:30Speaker 4: mind to start things off. Ticker in k E a
- 0:33Speaker 4: brutal day for the company, down about sixteen percent if
- 0:37Speaker 4: you look at the size and scope, the lowest level
- 0:39Speaker 4: since October of twenty fourteen. So non great investors not
- 0:43Speaker 4: really liking what came out of earning. So they said
- 0:46Speaker 4: that they expect revenue to decline this quarter and through
- 0:49Speaker 4: the rest of this year. But what we do know
- 0:50Speaker 4: is we've been getting reporting that the CEO, Elliott Hill,
- 0:54Speaker 4: was telling staff that he wants to shift from fixing
- 0:56Speaker 4: the business to actually driving growth. So we do understand
- 0:59Speaker 4: that he did to express some frustrations there. But I mean,
- 1:02Speaker 4: I've also just been looking at the performance of the company,
- 1:04Speaker 4: and we know that this has really been a company
- 1:06Speaker 4: that's been really struggling to chart a turnaround story. The
- 1:09Speaker 4: stock is not about thirty percent so far in twenty
- 1:12Speaker 4: twenty six. But interestingly, Wall Street I was looking about
- 1:16Speaker 4: fifty seven percent of the analysts still say to buy
- 1:18Speaker 4: the stock. But you know, I think in terms of
- 1:20Speaker 4: Wall Street in their perception today, at least they weren't
- 1:23Speaker 4: too pleased.
- 1:23Speaker 1: Wasn't it when the numbers crossed? They we didn't get
- 1:25Speaker 1: the outlook right away a country. We were all just
- 1:29Speaker 1: kind of waiting for our Yeah, and then we get it.
- 1:31Speaker 1: Weakness and greater China falling Converse sales or among management's
- 1:35Speaker 1: biggest challenges. China is a story we've been talking about
- 1:38Speaker 1: for a.
- 1:38Speaker 4: While with Nike, see China. I did know I thought
- 1:41Speaker 4: the Converse were timeless.
- 1:43Speaker 1: No, I don't know. I don't really wear Converse to
- 1:46Speaker 1: the Daughter Chick tailors, Right, yeah, I guess so, I
- 1:49Speaker 1: don't know. You know what's amazing.
- 1:51Speaker 3: They're aren't they what?
- 1:55Speaker 4: I'm curious?
- 1:56Speaker 3: Okay? Authentic? Well, we reported yesterday Lilly Meyer and Eliza
- 2:01Speaker 3: RONALDS Hannon that a potential suitor for Converse could be
- 2:03Speaker 3: an Authentic Brands group. They've expressed interest in buying converse
- 2:07Speaker 3: if it's put up for sale. According to people familiar
- 2:10Speaker 3: with the masters, can I.
- 2:11Speaker 1: Just tell you often when I am on a subway
- 2:14Speaker 1: or even this morning, I was walking through the platform,
- 2:17Speaker 1: the subway platform, and I wanted to take a video
- 2:19Speaker 1: as I walked along, because everybody has sneakers on, Yeah, everybody,
- 2:24Speaker 1: and they're all different kinds of brands. It is such
- 2:26Speaker 1: a crowded competitive field.
- 2:28Speaker 2: And I know nice all birds.
- 2:30Speaker 1: Right right, exactly, all Birds. I remember when they came
- 2:33Speaker 1: out bottom, bottom bottom, but I haven't bought them for
- 2:36Speaker 1: years a minute.
- 2:37Speaker 3: Right now, they're winding down after selling assets for thirty
- 2:39Speaker 3: nine million dollars.
- 2:40Speaker 1: The thing is, Nike is iconic, and I'm not quite sure.
- 2:44Speaker 1: Is it a bigger nut and harder to move? I
- 2:46Speaker 1: don't know, I don't know.
- 2:48Speaker 3: I just want to add one more thing. The interest
- 2:50Speaker 3: is long standing. Nike so far hasn't engaged in discussions
- 2:53Speaker 3: with the owner of Reeboking Champion, nor has Authentic made
- 2:56Speaker 3: any official overture. According to the people who asked not
- 2:59Speaker 3: to be identified because weren't authorized to speak publicly about the.
- 3:01Speaker 1: Situation, I'm going to go back to the CFO saying
- 3:03Speaker 1: they're going to be imaging costs carefully. So that's going
- 3:05Speaker 1: to put pressure on everybody as they as they try
- 3:07Speaker 1: to make things turn around. Sorry, we like this story too.
- 3:10Speaker 4: It's interesting. Thank you must little chapters to unfold. Well,
- 3:14Speaker 4: it's a going to name that ended in the green
- 3:15Speaker 4: today and we can't share some of intel I INTC
- 3:18Speaker 4: closing hired by about eight percent today. This is after
- 3:21Speaker 4: the company agreed to pay about fourteen billion dollars to
- 3:24Speaker 4: pay back half of a plant in Ireland that it
- 3:26Speaker 4: had previously sold to Apollo Global. So Da Davidson, the
- 3:30Speaker 4: analyst over there, did say that they think that this
- 3:32Speaker 4: move bodes well for the company's turnaround story. The deal
- 3:36Speaker 4: will apparently be funded with cash on hand and roughly
- 3:39Speaker 4: about six and a half billion dollars in new debt.
- 3:43Speaker 4: So clearly Wall Street was happy with this, and you know,
- 3:46Speaker 4: stock ending higher on the day. Sixty nine percent of
- 3:50Speaker 4: analysts on Wall Street do say though, to hold the stock.
- 3:53Speaker 4: We know that this company is up about thirty percent
- 3:55Speaker 4: so far in twenty twenty six.
- 3:57Speaker 1: Got to believe they're not going to do this unless
- 3:58Speaker 1: they're upbeate about the outlet look and make that spend.
- 4:01Speaker 1: Let's go on over to a couple of drugstocks. Yeah.
- 4:03Speaker 4: I mean, whenever you're looking for news, I feel that
- 4:05Speaker 4: you know your biotechs, your drug companies, healthcare, they're always moving.
- 4:09Speaker 4: I'm looking at shares of take r l Y as
- 4:12Speaker 4: well as Novo Nordis ADRs take your Vo. So we
- 4:15Speaker 4: did see Elilelly closing higher by about three percent. We
- 4:19Speaker 4: do know that the FDA did approve the drug maker's
- 4:22Speaker 4: obesity pill Fundio under the agency's National Priority Voucher Pilot program.
- 4:28Speaker 4: We know what's kind of been a back and forth
- 4:29Speaker 4: with these two companies. They're obviously always duking it out,
- 4:33Speaker 4: I mean, but both of them really struggled this year.
- 4:34Speaker 4: So it's really about which company is able to bring
- 4:37Speaker 4: new things online that their investors can really sink their
- 4:40Speaker 4: teeth into. And especially when we think about the fact
- 4:42Speaker 4: that the OBCD space has been a really you know, buoyant,
- 4:47Speaker 4: what popular industry as of late, this is where they
- 4:51Speaker 4: really want to lean into. But both stocks are down
- 4:52Speaker 4: so far this year. Ellellally shares down by about eleven
- 4:55Speaker 4: percent and Novo nordoius ADR is down by twenty eight percent.
- 4:59Speaker 4: In twenty twenty.
- 4:59Speaker 1: Six, big hit. All right, good stuff. Check out our
- 5:02Speaker 1: Stockmovers podcast, five minute episodes of the big winners and
- 5:05Speaker 1: losers in the stock market. Find it on Apple, Spotify,
- 5:07Speaker 1: or anywhere you get your podcasts.
- 5:10Speaker 2: The Stockmover's Report from Bloomberg Radio. Check back with us
- 5:14Speaker 2: throughout the day for the latest roundup of companies making
- 5:17Speaker 2: news on Wall Street and for the latest market moving headlines.
- 5:21Speaker 2: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
- 5:25Speaker 2: dot com, and on Applecarplay and Android Auto with the
- 5:28Speaker 2: Bloomberg Business app.